Erin Wright
Stock Analyst at Morgan Stanley
(4.57)
# 228
Out of 4,876 analysts
221
Total ratings
65.87%
Success rate
14.29%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $21 → $26 | $25.62 | +1.48% | 23 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Overweight | $166 → $181 | $167.82 | +7.85% | 11 | Jun 13, 2025 | |
| MCK McKesson | Maintains: Overweight | $745 → $770 | $732.47 | +5.12% | 7 | Jun 11, 2025 | |
| MOH Molina Healthcare | Initiates: Overweight | $364 | $296.00 | +22.97% | 1 | Jun 9, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $20 → $25 | $23.38 | +6.93% | 3 | May 9, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $548 → $558 | $534.72 | +4.35% | 13 | May 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $379 → $390 | $331.07 | +17.80% | 5 | May 5, 2025 | |
| PETS PetMed Express | Maintains: Underweight | $3.5 → $3.2 | $3.34 | -4.19% | 12 | Apr 17, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $19 | $19.72 | -3.63% | 8 | Mar 6, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $14 → $13 | $14.42 | -9.82% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $238 | $156.72 | +51.86% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $301 → $285 | $243.22 | +17.18% | 3 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $272 | $188.55 | +44.26% | 21 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $15.87 | +44.93% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $178.45 | -3.61% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $643 → $551 | $378.81 | +45.46% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.45 | -38.86% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $73.62 | -11.71% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $68.64 | +45.69% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $309.63 | +89.58% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $261.95 | +14.53% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $13.71 | +206.46% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $200.63 | +43.55% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $151.45 | +132.42% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $2.43 | +1,714.43% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $310.76 | -41.76% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $81.38 | -79.11% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $43.14 | +180.48% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $413.14 | +40.39% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $11.40 | +207.02% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $146.43 | +40.00% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $19.90 | -44.71% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $158.65 | -1.04% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $21.76 | +74.63% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $8.56 | +98.71% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $458.44 | -32.82% | 1 | Oct 25, 2017 |
Phibro Animal Health
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $25.62
Upside: +1.48%
Cardinal Health
Jun 13, 2025
Maintains: Overweight
Price Target: $166 → $181
Current: $167.82
Upside: +7.85%
McKesson
Jun 11, 2025
Maintains: Overweight
Price Target: $745 → $770
Current: $732.47
Upside: +5.12%
Molina Healthcare
Jun 9, 2025
Initiates: Overweight
Price Target: $364
Current: $296.00
Upside: +22.97%
BrightSpring Health Services
May 9, 2025
Maintains: Overweight
Price Target: $20 → $25
Current: $23.38
Upside: +6.93%
IDEXX Laboratories
May 5, 2025
Maintains: Overweight
Price Target: $548 → $558
Current: $534.72
Upside: +4.35%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $331.07
Upside: +17.80%
PetMed Express
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.34
Upside: -4.19%
Envista Holdings
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $19.72
Upside: -3.63%
Elanco Animal Health
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $14.42
Upside: -9.82%
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $156.72
Upside: +51.86%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $301 → $285
Current: $243.22
Upside: +17.18%
Feb 6, 2025
Maintains: Overweight
Price Target: $280 → $272
Current: $188.55
Upside: +44.26%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $15.87
Upside: +44.93%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $178.45
Upside: -3.61%
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $378.81
Upside: +45.46%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.45
Upside: -38.86%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $73.62
Upside: -11.71%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $68.64
Upside: +45.69%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $309.63
Upside: +89.58%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $261.95
Upside: +14.53%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $13.71
Upside: +206.46%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $200.63
Upside: +43.55%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $151.45
Upside: +132.42%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $2.43
Upside: +1,714.43%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $310.76
Upside: -41.76%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $81.38
Upside: -79.11%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $43.14
Upside: +180.48%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $413.14
Upside: +40.39%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $11.40
Upside: +207.02%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $146.43
Upside: +40.00%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $19.90
Upside: -44.71%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $158.65
Upside: -1.04%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $21.76
Upside: +74.63%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $8.56
Upside: +98.71%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $458.44
Upside: -32.82%